Page last updated: 2024-09-03

ci 934 and norfloxacin

ci 934 has been researched along with norfloxacin in 12 studies

Compound Research Comparison

Studies
(ci 934)
Trials
(ci 934)
Recent Studies (post-2010)
(ci 934)
Studies
(norfloxacin)
Trials
(norfloxacin)
Recent Studies (post-2010) (norfloxacin)
33023,077280912

Protein Interaction Comparison

ProteinTaxonomyci 934 (IC50)norfloxacin (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.02
DNA gyrase subunit AEscherichia coli K-120.6
DNA gyrase subunit BEscherichia coli K-120.6
DNA topoisomerase 4 subunit AStaphylococcus aureus3.5
Cytochrome P450 2C9 Homo sapiens (human)2.56
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.02
Cytochrome P450 2J2Homo sapiens (human)2.56
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.02
GABA theta subunitRattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.02

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19908 (66.67)18.7374
1990's3 (25.00)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MA; Domagala, JM; Mailloux, GB; Roland, GE; Suto, MJ1
Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG1
Culbertson, TP; Gambino, L; Sanchez, JP; Sesnie, JA1
Domagala, JM; Heifetz, CL; Hutt, MP; Mich, TF; Nichols, JB; Solomon, M; Worth, DF1
Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB1
García-March, FJ; Jaén-Oltra, J; Pérez-Giménez, F; Salabert-Salvador, MT; Tomás-Vert, F1
Avesani, V; Delmee, M1
Berlin, OG; Bruckner, DA; Young, LS1
Habiyaremye, I; Vandepitte, J; Verbist, L1
King, A; Phillips, I1
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C1
Floyd-Reising, SA; Hindler, JA; Kelley, SG; Young, LS1

Other Studies

12 other study(ies) available for ci 934 and norfloxacin

ArticleYear
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
    Journal of medicinal chemistry, 1992, Dec-11, Volume: 35, Issue:25

    Topics: Animals; Anti-Infective Agents; Cricetinae; Cricetulus; Fluoroquinolones; Microbial Sensitivity Tests; Structure-Activity Relationship

1992
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1991
Quinolone antibacterial agents substituted at the 7-position with spiroamines. Synthesis and structure-activity relationships.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:8

    Topics: Bacteria; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Piperazines; Pyrrolidines; Quinolines; Spiro Compounds; Structure-Activity Relationship

1990
1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Carboxylic Acids; Chemical Phenomena; Chemistry; Mice; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1988
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1986
Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods.
    Journal of medicinal chemistry, 2000, Mar-23, Volume: 43, Issue:6

    Topics: Algorithms; Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Neural Networks, Computer; Structure-Activity Relationship

2000
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines

1986
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines

1987
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2

    Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica

1987
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D

    Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines

1986
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Regression Analysis

1987
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Quinolines; Vancomycin

1987